October 25, 2017 – 7 p.m.
McNally Robinson Booksellers, 1120 Grant Avenue, Winnipeg
To assist in planning seating RSVP to: Research_Communications@umanitoba.ca
or call 204-474-6689
In the last half-decade, research has made significant advancements in breast cancer treatment. Although it remains the most common cancer diagnosis for Canadian women, the five-year survival rate for breast cancer patients is nearly 87 per cent. But not everything is so rosy. In nearly 30 per cent of patients, breast cancer tumours return after five years, significantly decreasing survival. Join our expert panel as they discuss the past 50 years of biological research and current efforts at the University of Manitoba to develop new ways of detecting breast cancer and new treatments for fighting recurrent breast cancer tumours and improving patient quality of life.
Dr. Afshin Raouf
Team Leader, Manitoba Breast Cancer Research Group, Associate Professor, Immunology Department/Regenerative Medicine Program
Dr. Marshall Pitz
Medical Oncologist, Director of Clinical Research, Research Institute of Hematology and Oncology, a joint institute of the University of Manitoba and CancerCare Manitoba
Dr. Sabine Hombach-Klonisch
Associate Professor, Section Head Gross Anatomy, Department of Human Anatomy and Cell Science, University of Manitoba, Member of the Manitoba Breast Cancer Research Group, Member of the Brain Tumor Research Alliance of Manitoba (BTRAM)
Dr. Stephen Pistorius
Research Scientist, CancerCare Manitoba & Research Institute of Hematology and Oncology, Professor (Physics & Astronomy), Associate Professor (Radiology), Director: Medical Physics Graduate Program, Vice Director: Biomedical Engineering Graduate Program, University of Manitoba